Monthly Archives: April 2017


Deferoxamina Noridem

19/04/2017 C.F.I. Srl has signed an agreement with the Greek company Demo SA for the exclusive sales and marketing of Deferoxamine Noridem (generic injectable) in Italy. Deferoxamine mesylate is indicated for the treatment of acute iron intoxication and of chronic iron overload due to transfusion-dependent anemias.

By |April 19th, 2017|News_CFI|0 Comments